RESUMEN

The discovery of the role of the ATP-binding cassette transporter A1 (ABCA1) in mediating apolipoprotein A-I-mediated efflux has led to a dramatic increase in our knowledge of the molecular mechanisms involved in cholesterol efflux and cellular metabolism. In this review, we discuss several aspects of ABCA1 regulation including i) transcriptional regulation, ii) substrate specificity and availability, iii) accessory proteins, iv) acceptor specificity and availability, and v) protein trafficking. The majority of studies of ABCA1 regulation to date have focused on the identification of promoter elements that determine ABCA1 gene transcription. Here we also review the potential functional role of ABCA1 in reverse cholesterol transport. Given the key role that ABCA1 plays in cholesterol homeostasis, it is likely that there are multiple mechanisms for controlling the overall transporter activity of ABCA1.

Asunto(s)

Transportadoras de Casetes de Unión a ATP/genética , Transportadoras de Casetes de Unión a ATP/fisiología , Regulación de la Expresión Génica , Transportador 1 de Casete de Unión a ATP , Transportadoras de Casetes de Unión a ATP/análisis , Animales , Apolipoproteína A-I/metabolismo , Colesterol/metabolismo , AMP Cíclico/farmacología , Citocinas/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Regiones Promotoras Genéticas , Receptores Citoplasmáticos y Nucleares/agonistas , Esteroles/farmacología , Factores de Transcripción/agonistas , Transcripción Genética

RESUMEN

ABCA1, the ATP-binding cassette protein mutated in Tangier disease, mediates the efflux of excess cellular sterol to apoA-I and thereby the formation of high density lipoprotein. The intracellular localization and trafficking of ABCA1 was examined in stably and transiently transfected HeLa cells expressing a functional human ABCA1-green fluorescent protein (GFP) fusion protein. The fluorescent chimeric ABCA1 transporter was found to reside on the cell surface and on intracellular vesicles that include a novel subset of early endosomes, as well as late endosomes and lysosomes. Studies of the localization and trafficking of ABCA1-GFP in the presence of brefeldin A or monensin, agents known to block intracellular vesicular trafficking, as well as apoA-I-mediated cellular lipid efflux, showed that: (i) ABCA1 functions in lipid efflux at the cell surface, and (ii) delivery of ABCA1 to lysosomes for degradation may serve as a mechanism to modulate its surface expression. Time-lapse fluorescence microscopy revealed that ABCA1-GFP-containing early endosomes undergo fusion, fission, and tubulation and transiently interact with one another, late endocytic vesicles, and the cell surface. These studies establish a complex intracellular trafficking pathway for human ABCA1 that may play important roles in modulating ABCA1 transporter activity and cellular cholesterol homeostasis.

Asunto(s)

Transportadoras de Casetes de Unión a ATP/metabolismo , Transportador 1 de Casete de Unión a ATP , Transportadoras de Casetes de Unión a ATP/genética , Animales , Apolipoproteína A-I/metabolismo , Transporte Biológico , Células CHO , Compartimento Celular , Cricetinae , Cicloheximida/farmacología , Endocitosis , Proteínas Fluorescentes Verdes , Células HeLa , Humanos , Inmunohistoquímica , Proteínas Luminiscentes/genética , Monensina/farmacología , Proteínas Recombinantes de Fusión/genética , Esteroles/metabolismo , Transfección

RESUMEN

To evaluate the biochemical and molecular mechanisms leading to glomerulosclerosis and the variable development of atherosclerosis in patients with familial lecithin cholesterol acyl transferase (LCAT) deficiency, we generated LCAT knockout (KO) mice and cross-bred them with apolipoprotein (apo) E KO, low density lipoprotein receptor (LDLr) KO, and cholesteryl ester transfer protein transgenic mice. LCAT-KO mice had normochromic normocytic anemia with increased reticulocyte and target cell counts as well as decreased red blood cell osmotic fragility. A subset of LCAT-KO mice accumulated lipoprotein X and developed proteinuria and glomerulosclerosis characterized by mesangial cell proliferation, sclerosis, lipid accumulation, and deposition of electron dense material throughout the glomeruli. LCAT deficiency reduced the plasma high density lipoprotein (HDL) cholesterol (-70 to -94%) and non-HDL cholesterol (-48 to -85%) levels in control, apoE-KO, LDLr-KO, and cholesteryl ester transfer protein-Tg mice. Transcriptome and Western blot analysis demonstrated up-regulation of hepatic LDLr and apoE expression in LCAT-KO mice. Despite decreased HDL, aortic atherosclerosis was significantly reduced (-35% to -99%) in all mouse models with LCAT deficiency. Our studies indicate (i) that the plasma levels of apoB containing lipoproteins rather than HDL may determine the atherogenic risk of patients with hypoalphalipoproteinemia due to LCAT deficiency and (ii) a potential etiological role for lipoproteins X in the development of glomerulosclerosis in LCAT deficiency. The availability of LCAT-KO mice characterized by lipid, hematologic, and renal abnormalities similar to familial LCAT deficiency patients will permit future evaluation of LCAT gene transfer as a possible treatment for glomerulosclerosis in LCAT-deficient states.

Asunto(s)

Arteriosclerosis/enzimología , Glomeruloesclerosis Focal y Segmentaria/enzimología , Fosfatidilcolina-Esterol O-Aciltransferasa/fisiología , Animales , Arteriosclerosis/fisiopatología , Secuencia de Bases , Cartilla de ADN , Glomeruloesclerosis Focal y Segmentaria/fisiopatología , Riñón/fisiopatología , Lípidos/sangre , Lipoproteínas/sangre , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microscopía Electrónica , Fosfatidilcolina-Esterol O-Aciltransferasa/sangre , Fosfatidilcolina-Esterol O-Aciltransferasa/genética , ARN Mensajero/genética

RESUMEN

ABCAI, a member of the ATP binding cassette family, mediates the efflux of excess cellular lipid to HDL and is defective in Tangier disease. The apolipoprotein acceptor specificity for lipid efflux by ABCAI was examined in stably transfected Hela cells, expressing a human ABCAI-GFP fusion protein. ApoA-I and all of the other exchangeable apolipoproteins tested (apoA-II, apoA-IV, apoC-I, apoC-II, apoC-III, apoE) showed greater than a threefold increase in cholesterol and phospholipid efflux from ABCAI-GFP transfected cells compared to control cells. Expression of ABCAI in Hela cells also resulted in a marked increase in specific binding of both apoA-I (Kd = 0.60 microg/mL) and apoA-II (Kd = 0.58 microg/mL) to a common binding site. In summary, ABCAI-mediated cellular binding of apolipoproteins and lipid efflux is not specific for only apoA-I but can also occur with other apolipoproteins that contain multiple amphipathic helical domains.

Asunto(s)

Transportadoras de Casetes de Unión a ATP/metabolismo , Apolipoproteínas/metabolismo , Metabolismo de los Lípidos , Transportador 1 de Casete de Unión a ATP , Transportadoras de Casetes de Unión a ATP/genética , Apolipoproteína A-I/metabolismo , Apolipoproteína A-II/metabolismo , Transporte Biológico Activo , Expresión Génica , Proteínas Fluorescentes Verdes , Células HeLa , Humanos , Cinética , Proteínas Luminiscentes/genética , Proteínas Luminiscentes/metabolismo , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Transfección

RESUMEN

The Niemann-Pick C1 (NPC1) protein and endocytosed low density lipoprotein (LDL)-derived cholesterol were shown to enrich separate subsets of vesicles containing lysosomal associated membrane protein 2. Localization of Rab7 in the NPC1-containing vesicles and enrichment of lysosomal hydrolases in the cholesterol-containing vesicles confirmed that these organelles were late endosomes and lysosomes, respectively. Lysobisphosphatidic acid, a lipid marker of the late endosomal pathway, was found in the cholesterol-enriched lysosomes. Recruitment of NPC1 to Rab7 compartments was stimulated by cellular uptake of cholesterol. The NPC1 compartment was shown to be enriched in glycolipids, and internalization of GalNAcbeta1-4[NeuAcalpha2-3]Galbeta1-4Glcbeta1-1'-ceramide (G(M2)) into endocytic vesicles depends on the presence of NPC1 protein. The glycolipid profiles of the NPC1 compartment could be modulated by LDL uptake and accumulation of lysosomal cholesterol. Expression in cells of biologically active NPC1 protein fused to green fluorescent protein revealed rapidly moving and flexible tubular extensions emanating from the NPC1-containing vesicles. We conclude that the NPC1 compartment is a dynamic, sterol-modulated sorting organelle involved in the trafficking of plasma membrane-derived glycolipids as well as plasma membrane and endocytosed LDL cholesterol.

Asunto(s)

Proteínas Portadoras/metabolismo , Colesterol/metabolismo , Endosomas/metabolismo , Glucolípidos/metabolismo , Glicoproteínas de Membrana/metabolismo , Animales , Transporte Biológico , Células CHO , Proteínas Portadoras/genética , Compartimento Celular , Células Cultivadas , Cricetinae , ADN Complementario/genética , Histocitoquímica , Humanos , Membranas Intracelulares/metabolismo , Péptidos y Proteínas de Señalización Intracelular , Lipoproteínas LDL , Lisosomas/metabolismo , Glicoproteínas de Membrana/genética , Proteína Niemann-Pick C1 , Transporte de Proteínas/fisiología , Fracciones Subcelulares , Transfección

RESUMEN

Niemann-Pick disease Type C (NP-C) is a progressive neurodegenerative disorder caused by mutations in the NPC1 gene and characterized by intracellular accumulation of cholesterol and sphingo-lipids. The major neuronal storage material in NP-C consists of gangliosides and other glycolipids, raising the possibility that the accumulation of these lipids may participate in the neurodegenerative process. To determine if ganglioside accumulation is a crucial factor in neuropathogenesis, we bred NP-C model mice with mice carrying a targeted mutation in GalNAcT, the gene encoding the beta-1-4GalNAc transferase responsible for the synthesis of GM2 and complex gangliosides. Unlike the NP-C model mice, these double mutant mice did not exhibit central nervous system (CNS) accumulation of gangliosides GM2 or of glycolipids GA1 and GA2. Histological analysis revealed that the characteristic neuronal storage pathology of NP-C disease was substantially reduced in the double mutant mice. By contrast, visceral pathology was similar in the NP-C and double mutant mice. Most notably, the clinical phenotype of the double mutant mice, in the absence of CNS ganglioside accumulation and associated neuronal pathology, did not improve. The results demonstrate that complex ganglioside storage, while responsible for much of the neuronal pathology, does not significantly influence the clinical phenotype of the NP-C model.

Asunto(s)

Gangliósidos/metabolismo , Neuronas/patología , Enfermedades de Niemann-Pick/genética , Enfermedades de Niemann-Pick/patología , Animales , Encéfalo/metabolismo , Encéfalo/patología , Modelos Animales de Enfermedad , Genotipo , Péptidos y Proteínas de Señalización Intracelular , Metabolismo de los Lípidos , Hígado/metabolismo , Hígado/patología , Ratones , Ratones Mutantes , Microscopía Electrónica , Mutación , Proteína Niemann-Pick C1 , Fenotipo , Proteínas/genética , Factores de Tiempo

RESUMEN

Steroidogenic cells represent unique systems for the exploration of intracellular cholesterol trafficking. We employed cytochemical and biochemical methods to explore the expression, regulation, and function of the Niemann-Pick C1 protein (NPC1) in human granulosa-lutein cells. NPC1 was localized in a subset of lysosome-associated membrane glycoprotein 2 (LAMP-2)-positive vesicles. By analyzing the sensitivity of NPC1 N-linked oligosaccharide chains to glycosidases and neuraminidase, evidence was obtained for movement of nascent NPC1 from the endoplasmic reticulum through the medial and trans compartments of the Golgi apparatus prior to its appearance in cytoplasmic vesicles. NPC1 protein content and the morphology and cellular distribution of NPC1-containing vesicles were not affected by treatment of the granulosa-lutein cells with 8-Br-cAMP, which stimulates cholesterol metabolism into progesterone. In contrast, steroidogenic acute regulatory (StAR) protein levels were increased by 8-Br-cAMP. Incubation of granulosa-lutein cells with low-density lipoprotein (LDL) in the presence of the hydrophobic amine, U18666A, caused accumulation of free cholesterol in granules, identified by filipin staining, that contained LAMP-2 and NPC1. These granules also stained for neutral lipid with Nile red, reflecting accumulation of LDL-derived cholesterol esters. LDL-stimulated progesterone synthesis was completely blocked by U18666A, leaving steroid output at levels similar to those of cells incubated in the absence of LDL. The hydrophobic amine also blocked the LDL augmentation of 8-Br-cAMP-stimulated progesterone synthesis, reducing steroid production to levels seen in cells stimulated with 8-Br-cAMP in the absence of LDL. Steroidogenesis recovered after U18666A was removed from the culture medium. U18666A treatment caused a 2-fold or more increase in NPC1 protein and mRNA levels, suggesting that disruption of NPC1's function activates a compensatory mechanism resulting in increased NPC1 synthesis. We conclude that the NPC1 compartment plays an important role in the trafficking of LDL-derived substrate in steroidogenic cells; that NPC1 expression is up-regulated when NPC1 action is blocked; and that the NPC1 compartment can be functionally separated from other intracellular pathways contributing substrate for steroidogenesis.

Asunto(s)

Proteínas Portadoras , Colesterol/metabolismo , Células de la Granulosa/metabolismo , Células Lúteas/metabolismo , Glicoproteínas de Membrana , Proteínas/metabolismo , Esteroides/biosíntesis , 8-Bromo Monofosfato de Adenosina Cíclica/farmacología , Androstenos/farmacología , Animales , Anticolesterolemiantes/farmacología , Transporte Biológico , Células CHO , Células Cultivadas , Cricetinae , Femenino , Expresión Génica/efectos de los fármacos , Células de la Granulosa/citología , Células de la Granulosa/efectos de los fármacos , Humanos , Líquido Intracelular/metabolismo , Péptidos y Proteínas de Señalización Intracelular , Lipoproteínas LDL/farmacología , Células Lúteas/citología , Células Lúteas/efectos de los fármacos , Lisosomas/metabolismo , Proteína Niemann-Pick C1 , Fosfoproteínas/biosíntesis , Progesterona/biosíntesis , Progestinas/biosíntesis , Proteínas/genética

RESUMEN

Niemann-Pick type C (NPC) disease, characterized by accumulation of low density lipoprotein-derived free cholesterol in lysosomes, is caused by mutations in the NPC1 gene. We examined the ability of wild-type NPC1 and NPC1 mutants to correct the NPC sterol trafficking defect and their subcellular localization in CT60 cells. Cells transfected with wild-type NPC1 expressed 170- and 190-kDa proteins. Tunicamycin treatment resulted in a 140-kDa protein, the deduced size of NPC1, suggesting that NPC1 is N-glycosylated. Mutation of all four asparagines in potential N-terminal N-glycosylation sites to glutamines resulted in a 20-kDa reduction of the expressed protein. Proteins with a single N-glycosylation site mutation localized to late endosome/lysosomal compartments, as did wild-type NPC1, and each corrected the cholesterol trafficking defect. However, mutation of all four potential N-glycosylation sites reduced ability to correct the NPC phenotype commensurate with reduced expression of the protein. Mutations in the putative sterol-sensing domain resulted in inactive proteins targeted to lysosomal membranes encircling cholesterol-laden cores. N-terminal leucine zipper motif mutants could not correct the NPC defect, although they accumulated in lysosomal membranes. We conclude that NPC1 is a glycoprotein that must have an intact sterol-sensing domain and leucine zipper motif for cholesterol-mobilizing activity.

Asunto(s)

Proteínas Portadoras , Glicoproteínas de Membrana , Mutagénesis Sitio-Dirigida , Enfermedades de Niemann-Pick/genética , Proteínas/genética , Proteínas/metabolismo , Esteroles/metabolismo , Sustitución de Aminoácidos , Animales , Asparagina , Sitios de Unión , Células CHO , Colesterol/metabolismo , Cricetinae , Endosomas/metabolismo , Glutamina , Glicosilación , Humanos , Membranas Intracelulares/metabolismo , Péptidos y Proteínas de Señalización Intracelular , Leucina Zippers , Lisosomas/metabolismo , Peso Molecular , Proteína Niemann-Pick C1 , Fenotipo , Mutación Puntual , Proteínas/química , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Transfección

RESUMEN

Niemann-Pick C disease (NP-C) is a neurovisceral lysosomal storage disorder. A variety of studies have highlighted defective sterol trafficking from lysosomes in NP-C cells. However, the heterogeneous nature of additional accumulating metabolites suggests that the cellular lesion may involve a more generalized block in retrograde lysosomal trafficking. Immunocytochemical studies in fibroblasts reveal that the NPC1 gene product resides in a novel set of lysosome-associated membrane protein-2 (LAMP2)(+)/mannose 6-phosphate receptor(-) vesicles that can be distinguished from cholesterol-enriched LAMP2(+) lysosomes. Drugs that block sterol transport out of lysosomes also redistribute NPC1 to cholesterol-laden lysosomes. Sterol relocation from lysosomes in cultured human fibroblasts can be blocked at 21 degrees C, consistent with vesicle-mediated transfer. These findings suggest that NPC1(+) vesicles may transiently interact with lysosomes to facilitate sterol relocation. Independent of defective sterol trafficking, NP-C fibroblasts are also deficient in vesicle-mediated clearance of endocytosed [14C]sucrose. Compartmental modeling of the observed [14C]sucrose clearance data targets the trafficking defect caused by mutations in NPC1 to an endocytic compartment proximal to lysosomes. Low density lipoprotein uptake by normal cells retards retrograde transport of [14C]sucrose through this same kinetic compartment, further suggesting that it may contain the sterol-sensing NPC1 protein. We conclude that a distinctive organelle containing NPC1 mediates retrograde lysosomal transport of endocytosed cargo that is not restricted to sterol.

Asunto(s)

Proteínas Portadoras , Lisosomas/metabolismo , Enfermedades de Niemann-Pick/metabolismo , Proteínas/metabolismo , Secuencia de Aminoácidos , Anticuerpos , Antígenos CD/metabolismo , Transporte Biológico , Compartimento Celular , Colesterol/metabolismo , Endocitosis , Humanos , Péptidos y Proteínas de Señalización Intracelular , Proteína 2 de la Membrana Asociada a los Lisosomas , Proteínas de Membrana de los Lisosomas , Glicoproteínas de Membrana/metabolismo , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Proteína Niemann-Pick C1 , Enfermedades de Niemann-Pick/genética , Proteínas/genética , Receptor IGF Tipo 2/metabolismo , Relación Estructura-Actividad , Sacarosa/metabolismo

RESUMEN

Niemann-Pick type C (NPC) disease is an inherited lipid storage disorder that affects the viscera and central nervous system. A characteristic feature of NPC cells is the lysosomal accumulation of low density lipoprotein-derived cholesterol. To elucidate important structural features of the recently identified NPC1 gene product defective in NPC disease, we examined the ability of wild-type NPC1 and NPC1 mutants to correct the excessive lysosomal storage of low density lipoprotein-derived cholesterol in a model cell line displaying the NPC cholesterol-trafficking defect (CT60 Chinese hamster ovary cells). CT60 cells transfected with human wild-type NPC1 contained immunoreactive proteins of 170 and 190 kDa localized to the lysosomal/endosomal compartment. Wild-type NPC1 protein corrected the NPC cholesterol-trafficking defect in the CT60 cells. Mutation of conserved cysteine residues in the NPC1 N terminus to serine residues resulted in proteins targeted to lysosomal membranes encircling cholesterol-laden cores, whereas deletion of the C-terminal 4-aa residues containing the LLNF lysosome-targeting motif resulted in the expression of protein localized to the endoplasmic reticulum. None of these mutant NPC1 proteins corrected the NPC cholesterol-trafficking defect in CT60 cells. We conclude that transport of the NPC1 protein to the cholesterol-laden lysosomal compartment is essential for expression of its biological activity and that domains in the N terminus of the NPC1 protein are critical for mobilization of cholesterol from lysosomes.

Asunto(s)

Proteínas Portadoras , Colesterol/metabolismo , Lisosomas/metabolismo , Glicoproteínas de Membrana , Proteínas/metabolismo , Sustitución de Aminoácidos , Animales , Células CHO , Cricetinae , Retículo Endoplásmico/metabolismo , Filipina/análisis , Proteínas Fluorescentes Verdes , Humanos , Péptidos y Proteínas de Señalización Intracelular , Proteínas Luminiscentes/metabolismo , Mutagénesis Sitio-Dirigida , Proteína Niemann-Pick C1 , Enfermedades de Niemann-Pick/genética , Enfermedades de Niemann-Pick/metabolismo , Proteínas/química , Proteínas/genética , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Eliminación de Secuencia , Transfección

RESUMEN

Niemann-Pick type C disease (NP-C) is an inherited neurovisceral lipid storage disorder characterized by progressive neurodegeneration. Most cases of NP-C result from inactivating mutations of NPC1, a recently identified member of a family of genes encoding membrane-bound proteins containing putative sterol sensing domains. By using a specific antipeptide antibody to human NPC1, we have here investigated the cellular and subcellular localization and regulation of NPC1. By light and electron microscopic immunocytochemistry of monkey brain, NPC1 was expressed predominantly in perisynaptic astrocytic glial processes. At a subcellular level, NPC1 localized to vesicles with the morphological characteristics of lysosomes and to sites near the plasma membrane. Analysis of the temporal and spatial pattern of neurodegeneration in the NP-C mouse, a spontaneous mutant model of human NP-C, by amino-cupric-silver staining, showed that the terminal fields of axons and dendrites are the earliest sites of degeneration that occur well before the appearance of a neurological phenotype. Western blots of cultured human fibroblasts and monkey brain homogenates revealed NPC1 as a 165-kDa protein. NPC1 levels in cultured fibroblasts were unchanged by incubation with low density lipoproteins or oxysterols but were increased 2- to 3-fold by the drugs progesterone and U-18666A, which block cholesterol transport out of lysosomes, and by the lysosomotropic agent NH4Cl. These studies show that NPC1 in brain is predominantly a glial protein present in astrocytic processes closely associated with nerve terminals, the earliest site of degeneration in NP-C. Given the vesicular localization of NPC1 and its proposed role in mediating retroendocytic trafficking of cholesterol and other lysosomal cargo, these results suggest that disruption of NPC1-mediated vesicular trafficking in astrocytes may be linked to neuronal degeneration in NP-C.

Asunto(s)

Astrocitos/metabolismo , Encéfalo/patología , Proteínas Portadoras , Glicoproteínas de Membrana , Enfermedades de Niemann-Pick/patología , Proteínas/análisis , Secuencia de Aminoácidos , Animales , Anticuerpos , Astrocitos/patología , Axones/patología , Axones/ultraestructura , Encéfalo/citología , Encéfalo/metabolismo , Células CHO , Células Cultivadas , Cricetinae , Dendritas/patología , Dendritas/ultraestructura , Femenino , Fibroblastos , Humanos , Inmunohistoquímica , Recién Nacido , Péptidos y Proteínas de Señalización Intracelular , Macaca fascicularis , Masculino , Ratones , Microscopía Inmunoelectrónica , Datos de Secuencia Molecular , Degeneración Nerviosa/metabolismo , Degeneración Nerviosa/patología , Neuroglía/metabolismo , Neuroglía/patología , Neuronas/citología , Neuronas/patología , Proteína Niemann-Pick C1 , Enfermedades de Niemann-Pick/metabolismo , Proteínas/genética , Proteínas/inmunología , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Proteínas Recombinantes/inmunología , Transfección

RESUMEN

Niemann-Pick type C (NP-C) disease, a fatal neurovisceral disorder, is characterized by lysosomal accumulation of low density lipoprotein (LDL)-derived cholesterol. By positional cloning methods, a gene (NPC1) with insertion, deletion, and missense mutations has been identified in NP-C patients. Transfection of NP-C fibroblasts with wild-type NPC1 cDNA resulted in correction of their excessive lysosomal storage of LDL cholesterol, thereby defining the critical role of NPC1 in regulation of intracellular cholesterol trafficking. The 1278-amino acid NPC1 protein has sequence similarity to the morphogen receptor PATCHED and the putative sterol-sensing regions of SREBP cleavage-activating protein (SCAP) and 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase.

Asunto(s)

Proteínas Portadoras , Colesterol/metabolismo , Proteínas de Drosophila , Glicoproteínas de Membrana , Enfermedades de Niemann-Pick/genética , Proteínas/genética , Secuencia de Aminoácidos , LDL-Colesterol/metabolismo , Mapeo Cromosómico , Cromosomas Humanos Par 18 , Clonación Molecular , Homeostasis , Humanos , Hidroximetilglutaril-CoA Reductasas/química , Proteínas de Insectos/química , Péptidos y Proteínas de Señalización Intracelular , Lisosomas/metabolismo , Proteínas de la Membrana/química , Datos de Secuencia Molecular , Mutación , Proteína Niemann-Pick C1 , Enfermedades de Niemann-Pick/metabolismo , Polimorfismo Conformacional Retorcido-Simple , Proteínas/química , Proteínas/fisiología , Receptores de Superficie Celular/química , Homología de Secuencia de Aminoácido , Transfección

RESUMEN

Niemann-Pick C disease (NP-C) is a rare inborn error of metabolism with hepatic involvement and neurological sequelae that usually manifest in childhood. Although in vitro studies have shown that the lysosomal distribution of LDL-derived cholesterol is defective in cultured cells of NP-C subjects, no unusual characteristics mark the plasma lipoprotein profiles. We set out to determine whether anomalies exist in vivo in the cellular distribution of newly synthesized, HDL-derived or LDL-derived cholesterol under physiologic conditions in NP-C subjects. Three affected and three normal male subjects were administered [14C]mevalonate as a tracer of newly synthesized cholesterol and [3H]cholesteryl linoleate in either HDL or LDL to trace the distribution of lipoprotein-derived free cholesterol. The rate of appearance of free [14C]- and free [3H]cholesterol in the plasma membrane was detected indirectly by monitoring their appearance in plasma and bile. The plasma disappearance of [3H]cholesteryl linoleate was slightly faster in NP-C subjects regardless of its lipoprotein origin. Appearance of free [14C] cholesterol ill the plasma (and in bile) was essentially identical in normal and affected individuals as was the initial appearance of free [3H]cholesterol derived from HDL, observed before extensive exchange occurred of the [3H]cholesteryl linoleate among lipoproteins. In contrast, the rate of appearance of LDL-derived free [3H]cholesterol in the plasma membrane of NP-C subjects, as detected in plasma and bile, was retarded to a similar extent that LDL cholesterol metabolism was defective in cultured fibroblasts of these affected subjects. These findings show that intracellular distribution of both newly synthesized and HDL-derived cholesterol are essentially unperturbed by the NP-C mutation, and therefore occur by lysosomal-independent paths. In contrast, in NP-C there is defective trafficking of LDL-derived cholesterol to the plasma membrane in vivo as well as in vitro. The in vivo assay of intracellular cholesterol distribution developed herein should prove useful to quickly evaluate therapeutic interventions for NP-C.

Asunto(s)

Ésteres del Colesterol/metabolismo , Colesterol/metabolismo , Lipoproteínas HDL/metabolismo , Lipoproteínas LDL/metabolismo , Enfermedades de Niemann-Pick/genética , Enfermedades de Niemann-Pick/metabolismo , Adulto , Bilis/química , Bilis/metabolismo , Colesterol/sangre , Ésteres del Colesterol/sangre , Fibroblastos , Histocitoquímica , Humanos , Masculino , Ácido Mevalónico/administración & dosificación , Ácido Mevalónico/metabolismo , Mutación

RESUMEN

The sterol binding agent 2-hydroxypropyl-beta-cyclodextrin is shown to be a convenient and useful experimental tool to probe intracellular pathways of cholesterol transport. Biochemical and cytochemical studies reveal that cyclodextrin specifically removes plasma membrane cholesterol. Depletion of plasma membrane sphingomyelin greatly accelerated cyclodextrin-mediated cholesterol removal. Cholesterol arriving at the plasma membrane from lysosomes and the endoplasmic reticulum was also removed by cyclodextrin. Cellular cholesterol esterification linked to the mobilization of cholesterol from lysosomes was strongly attenuated by cyclodextrin, suggesting that the major portion of endocytosed cholesterol is delivered from lysosomes to the endoplasmic reticulum via the plasma membrane. Evidence for translocation of lysosomal cholesterol to the endoplasmic reticulum by a plasma membrane-independent pathway is provided by the finding that cyclodextrin loses its ability to suppress esterification when plasma membrane sphingomyelin is depleted. The Golgi apparatus appears to play an active role in directing the relocation of lysosomal cholesterol to the plasma membrane since brefeldin A also abrogated cyclodextrin-mediated suppression of cholesterol esterification. Using cyclodextrin we further show that attenuated esterification of lysosomal cholesterol in Niemann-Pick C cells reflects defective translocation of cholesterol to the plasma membrane that may be linked to abnormal Golgi trafficking.

Asunto(s)

LDL-Colesterol/metabolismo , Ciclodextrinas/metabolismo , beta-Ciclodextrinas , 2-Hidroxipropil-beta-Ciclodextrina , Transporte Biológico , Compartimento Celular , Membrana Celular/metabolismo , Técnicas de Cultivo , Ciclodextrinas/química , Aparato de Golgi/metabolismo , Humanos , Lisosomas/metabolismo , Microscopía Fluorescente , Sondas Moleculares , Esfingomielinas/metabolismo

RESUMEN

High dietary strontium induces rickets in both calcium-replete and calcium-deficient animals. To test the hypothesis that strontium directly perturbs complexed acidic phospholipid (CPLX) metabolism and thus, mineralization, the effect of strontium treatment on CPLX formation was studied in solution, in culture, and in growing rats. Synthetic CPLX containing calcium or strontium were found to be similar in composition. Strontium, however, appeared to incorporate into CPLX less avidly than calcium. Mineralizing chick limb bud mesenchymal cell cultures treated with strontium demonstrated a significantly increased CPLX content and decreased 45Ca uptake compared to calcium-treated cultures. Long bones from young growing rats fed a diet supplemented with strontium demonstrated defective mineralization based on radiologic and histologic analyses. Metaphyseal bone of strontium-fed rats contained significantly greater amounts of CPLX and had significantly lower ash weights compared with control bone. Thus, treatment of mineralizing tissues with strontium both in vitro and in vivo resulted in defective mineralization and an accumulation of CPLX. Strontium appears to perturb mineralization, in part, by a direct effect on the cells of mineralizing tissues.

Asunto(s)

Densidad Ósea/efectos de los fármacos , Calcificación Fisiológica/efectos de los fármacos , Calcio/metabolismo , Fosfolípidos/metabolismo , Estroncio/toxicidad , Animales , Células Cultivadas , Embrión de Pollo , Extremidades/embriología , Alimentos Fortificados , Masculino , Mesodermo/efectos de los fármacos , Mesodermo/metabolismo , Radiografía , Ratas , Ratas Sprague-Dawley , Tibia/diagnóstico por imagen , Tibia/efectos de los fármacos

RESUMEN

We have evaluated the utility of the hepatoma-derived hybrid cell line, WIF-B, for in vitro studies of polarized hepatocyte functions. The majority (> 70%) of cells in confluent culture formed closed spaces with adjacent cells. These bile canalicular-like spaces (BC) accumulated fluorescein, a property of bile canaliculi in vivo. By indirect immunofluorescence, six plasma membrane (PM) proteins showed polarized distributions similar to rat hepatocytes in situ. Four apical PM proteins were concentrated in the BC membrane of WIF-B cells. Microtubules radiated from the BC (apical) membrane, and actin and foci of gamma-tubulin were concentrated in this region. The tight junction-associated protein ZO-1 was present in belts marking the boundary between apical and basolateral PM domains. We explored the functional properties of this boundary in living cells using fluorescent membrane lipid analogs and soluble tracers. When cells were incubated at 4 degrees C with a fluorescent analog of sphingomyelin, only the basolateral PM was labeled. In contrast, when both PM domains were labeled by de novo synthesis of fluorescent sphingomyelin from ceramide, fluorescent lipid could only be removed from the basolateral domain. These data demonstrate the presence of a barrier to the lateral diffusion of lipids between the PM domains. However, small soluble FITC-dextrans (4,400 mol wt) were able to diffuse into BC, while larger FITC-dextrans were restricted to various degrees depending on their size and incubation temperature. At 4 degrees C, the surface labeling reagent sNHS-LC-biotin (557 mol wt) had access to the entire PM, but streptavidin (60,000 mol wt), which binds to biotinylated molecules, was restricted to only the basolateral domain. Such differential accessibility of well-characterized probes can be used to mark each membrane domain separately. These results show that WIF-B cells are a suitable model to study membrane trafficking and targeting in hepatocytes in vitro.

Asunto(s)

Hígado/citología , Hígado/ultraestructura , Proteínas de la Membrana/análisis , Animales , Carcinoma Hepatocelular/patología , Membrana Celular/ultraestructura , Células Cultivadas , Ceramidas/metabolismo , Dextranos , Fluoresceína-5-Isotiocianato/análogos & derivados , Técnica del Anticuerpo Fluorescente , Humanos , Células Híbridas , Uniones Intercelulares/ultraestructura , Hígado/metabolismo , Neoplasias Hepáticas/patología , Proteínas de la Membrana/metabolismo , Microtúbulos/metabolismo , Microtúbulos/ultraestructura , Modelos Biológicos , Fosfoproteínas/análisis , Ratas , Esfingolípidos/análisis , Esfingolípidos/metabolismo , Esfingomielinas/análisis , Esfingomielinas/metabolismo , Proteína de la Zonula Occludens-1